Title: Head of Technology Marketing

Adimab (https://www.adimab.com) is the leading technology provider for therapeutic antibody drug discovery, focusing solely on our partnerships without pursuing an internal product pipeline. Since 2009, we have partnered (https://www.adimab.com/partnering) with over 100 pharmaceutical and biotechnology companies, generating more than 500 therapeutic programs, of which more than 70 have entered clinical trials.  

Role Overview:

We are seeking a driven and committed person to lead the technology marketing efforts for new business at Adimab. Building on the strong partnerships and industry connections already in place, this person will drive new business by extending Adimab’s external scientific presence in the biotech space. Through conference presentations and outreach to potential new partners, this person will increase Adimab’s industry footprint. As a primarily a marketing role, this person will help to develop the business strategy with the Chief Business Officer, the Strategic Alliances team, and the Platform Transfer team. Additional collaboration with the scientific leadership team to  launch new technologies and ensure strategic alignment between Adimab’s future capabilities and the needs of partners.

Responsibilities: 

• Significant presence in the industry

• Regular attendee and presenter at conferences 

• Outreach to potential new partners that leads to new deals

• Primary strategist for marketing and new business development

• Lead the launch of new technologies to existing and new potential partners

  Needed Upon Hire:

• PhD in a life science

• 10 years prior relevant experience in an externally facing scientific or business development role

• Enthusiasm for significant travel 

• Ability to work and communicate effectively in a matrix environment

• Effective and engaging communicator 

• Proven ability to think strategically 

  Come join us!

Our integrated antibody discovery and engineering platform provides unprecedented speed from antigen to purified, full-length human IgGs with exquisite specificity and biophysical behavior. We offer fundamental advantages by delivering diverse panels of antibodies that meet the most demanding standards for affinity, epitope specificity, species cross-reactivity, and developability. We enable our partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

As a profitable privately-held biotech company, we take a long-term view on value creation and make substantial investments in technology development, research, and our people. We proudly promote meritocracy and reward employees who are productive, use their resources wisely, and make meaningful contributions to the team. We offer individually tailored compensation packages comprised of a competitive salary, meaningful equity, a 2:1 401(k) match, and comprehensive health care benefits.

Powered by JazzHR